Therapy News and Research

RSS

$1 million grant advances research into RNA-DNA virus evolution

Much remains unknown about the origin of viruses and how they evolve - but hunting for answers has been the focus of Portland State biology professor Ken Stedman's eXtreme Virus Lab for the past 25 years.

27 Oct 2026

A loneliness trial puts personalized nature-based support on the research agenda

In a randomized trial involving 320 adults experiencing loneliness, researchers found that loneliness scores declined in both a facilitated nature-based group program and an active signposting group, with no significant difference between them at three months. Neither approach significantly improved health-related quality of life, while exploratory analyses suggested that people with lower emotional wellbeing might benefit more from facilitated group activities.

27 Oct 2026

Low vitamin B12 is linked to heart disease. Supplements tell a different story

A narrative review published in Nutrition Journal examines how vitamin B12 deficiency may contribute to cardiovascular disease through elevated homocysteine, endothelial dysfunction, oxidative stress and altered methylation. The authors found that B12 supplementation has not consistently prevented heart attacks or cardiovascular deaths in clinical trials, although combined B-vitamin therapy may modestly reduce stroke risk, particularly in populations without folic acid fortification.

27 Oct 2026

Men with lower testosterone at 31 reported good health 15 years later

Researchers analyzed testosterone concentrations measured at age 31 in 2,691 Finnish men and assessed self-reported health, medical conditions, and quality of life at age 46. Men across testosterone quartiles generally reported good health and excellent quality of life, while differences in metabolic and gastrointestinal conditions lost statistical significance after adjustment for waist circumference.

27 Oct 2026

Non-drug and non-surgical low back pain treatments are highly cost-effective options

Non-drug and non-surgical treatments for low back pain, including psychological support, exercise and self-management strategies are cost-effective interventions, according to a study published October 27th in the open access journal PLOS Medicine by Manuela Loureiro Ferreira from the George Institute for Global Health, Australia, and colleagues.

27 Oct 2026

Updated ASTRO guidelines recommend shorter radiation courses for prostate cancer

An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence-based recommendations on the use of hypofractionated radiation therapy for patients with localized prostate cancer.

27 Oct 2026

Baylor researchers discover how glioblastoma hijacks nearby brain cells

Researchers at Baylor College of Medicine have discovered a new strategy that glioblastoma, the most common and aggressive form of adult brain cancer, uses to fuel its own growth.

27 Oct 2026

Endometrial cancer rates rise sharply among younger South Texas women

An Upper-South region of Texas including San Antonio and Bexar County had the state's highest hysterectomy-corrected incidence of endometrial cancer and the largest increase over time, a study led by scientists at The University of Texas at San Antonio Health Science Center and the National Cancer Institute showed.

27 Oct 2026

Vitamin B5 derivative pantethine helps prevent and alleviate psoriasis symptoms in mice

Researchers in China have discovered that the vitamin B5 derivative pantethine limits the activity of immune cells that are key contributors to autoimmune diseases such as psoriasis.

27 Oct 2026

LINAC-based radiosurgery effectively reduces seizures but causes significant side effects

Drug-resistant epilepsy types, such as mesial temporal lobe epilepsy (MTLE), are surgically managed through anterior temporal lobectomy (ATL).

27 Oct 2026

Breakthrough targeted therapy shows strong precision in treating chronic myeloid leukemia

A more effective and better-tolerated treatment for chronic myeloid leukemia (CML) could improve quality of life for people living with the disease.

27 Oct 2026

Black Dog Institute announces Australian-first ketamine treatment trial for Australia’s emergency service workers

Black Dog Institute has today announced a new clinical trial investigating whether ketamine, combined with evidence-based psychological therapy, can improve treatment outcomes for Australia's emergency service workers living with post-traumatic stress disorder (PTSD).

27 Oct 2026

Patients with a form of advanced lung cancer lived 56 percent longer without their disease progressing after receiving radiotherapy in addition to standard treatment

Patients with an advanced form of lung cancer lived 56 percent longer without their disease progressing when radiotherapy was added to the standard of care whole-body therapy, including chemotherapy and/or immunotherapy, according to initial results from a clinical trial presented at the 2026 European Society for Medical Oncology (ESMO) Congress.

27 Oct 2026

Study establishes new perioperative standard in prostate cancer

An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer with apalutamide - a next-generation neoadjuvant androgen-receptor pathway inhibitor (ARPI) - plus hormone therapy before and after prostate cancer surgery, was further validated by a substudy demonstrating a reduced risk of metastasis or death compared with standard of care.

27 Oct 2026

New alpha-emitting radiopharmaceutical therapy achieves strong responses in advanced prostate cancer

A new alpha-emitting radiopharmaceutical therapy (RPT) for advanced prostate cancer was well tolerated, with no dose-limiting toxicities observed, and showed encouraging signs of antitumor activity, according to a phase 1 trial published in The Journal of Nuclear Medicine's Late-Breaking Fast Track.

26 Oct 2026

Immunotherapy combination sets a new standard of care for extensive-stage small cell lung cancer

In patients with extensive-stage small cell lung cancer (ES-SCLC), tarlatamab, a bispecific T-cell engager, plus durvalumab as first-line maintenance therapy extended median overall survival by more than eight months, more than tripled progression-free survival, and reduced the risk of death by 58% compared to durvalumab alone, according to results of the phase 3 open-label, multicenter, randomized DeLLphi-305 study, which was presented by Jacob Sands, MD, Associate Chief of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute, during the Presidential Symposium at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain, on Oct. 24.

26 Oct 2026

New drug effectively decreases recurrence of and death from endometrial cancer

A new drug is effective at decreasing recurrence of and death from endometrial cancer, a landmark international study shows.

26 Oct 2026

Proteins linked to Alzheimer's found to assist sperm cells

Unexpectedly, a kind of protein that is usually linked with diseases in the brain may play a vital role in semen, helping shepherd genetic material into sperm cells, scientists at Columbia's Zuckerman Institute report today in the research journal Molecular Cell.

26 Oct 2026

Implantable drug-delivery device could help prevent recurrence of glioblastoma

Patients with glioblastoma, an aggressive type of brain tumor, usually undergo surgery to remove the tumor. However, it's difficult for surgeons to remove all of the cancer cells, and the tumor often recurs.

26 Oct 2026

Simple drug adjustment reduces kidney damage during septic shock surgery

A simple adjustment to drugs given during operations for septic shock could prevent thousands of patients suffering kidney damage, according to a major trial.

26 Oct 2026

Therapy News and Research

$1 million grant advances research into RNA-DNA virus evolution

A loneliness trial puts personalized nature-based support on the research agenda

Low vitamin B12 is linked to heart disease. Supplements tell a different story

Men with lower testosterone at 31 reported good health 15 years later

Non-drug and non-surgical low back pain treatments are highly cost-effective options

Updated ASTRO guidelines recommend shorter radiation courses for prostate cancer

Baylor researchers discover how glioblastoma hijacks nearby brain cells

Endometrial cancer rates rise sharply among younger South Texas women

Vitamin B5 derivative pantethine helps prevent and alleviate psoriasis symptoms in mice

LINAC-based radiosurgery effectively reduces seizures but causes significant side effects

Breakthrough targeted therapy shows strong precision in treating chronic myeloid leukemia

Black Dog Institute announces Australian-first ketamine treatment trial for Australia’s emergency service workers

Patients with a form of advanced lung cancer lived 56 percent longer without their disease progressing after receiving radiotherapy in addition to standard treatment

Study establishes new perioperative standard in prostate cancer

New alpha-emitting radiopharmaceutical therapy achieves strong responses in advanced prostate cancer

Immunotherapy combination sets a new standard of care for extensive-stage small cell lung cancer

New drug effectively decreases recurrence of and death from endometrial cancer

Proteins linked to Alzheimer's found to assist sperm cells

Implantable drug-delivery device could help prevent recurrence of glioblastoma

Simple drug adjustment reduces kidney damage during septic shock surgery

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News